A medical malpractice lawsuit ended in victory for it’s California plaintiff. In 2007, Ana Jimenez-Salgado, received the news that cells obtained from a biopsy of breast tissue were cancerous, leading her medical providers at a Los Angeles county hospital to perform a double mastectomy. But when she later went to undergo reconstructive surgery, the hospital pathologists examined the remaining tissue and determined she never had cancer.
She filed a lawsuit and was awarded $198,000 for a grave misdiagnosis. Negligence befell the hospital when they failed to closely examine outside pathology reports, or even perform their own tests to ensure the presence of cancerous cells. And as if removing the woman’s natural breasts for no reason wasn’t enough, they negligently performed the reconstructive surgery.
Medical Malpractice Lawyers in New Jersey and Philadelphia
If you or a loved one have suffered at the hands of a negligent medical provider, you’ll need the help of medical malpractice lawyers to determine whether or not you are entitled to compensation for your losses. If you are uncomfortable with the treatment you are receiving, or questioning the reliability of your medical providers, do not wait until something irreversible takes place.
Contact the Mininno Law Office for a free case evaluation. You may also call for a free consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.
The members of our team are extremely skilled in earning victims of medical negligence the full and fair compensation they deserve.
This for-profit, corporately owned nursing home was cited for a variety of deficiencies from November 2008 through October 2010. The citations were in a wide variety of categories including, among others, nutrition/dietary needs, living environment, and pharmaceutical responsibilities. For example, it indicated that some residents were affected by the fact that the pharmacy made medication errors of more than 5%. These errors are defined as administering the wrong drugs, administering the wrong doses, or administering drugs ate the wrong times. Medication errors can lead to many serious health issues. 
As a 
On the day of her daughter Cassie’s birth, Dr. Lisa Yang and her colleagues administered drugs and forced the kind of birth deemed nearly impossible early on in Heather’s pregnancy. The drugs administered were supposed to assist the uterus in contracting, and eventually the baby would be expelled. However, because of her mother’s condition, and because of Cassie’s size, which the doctors failed to consider, Cassie’s head became stuck. 
For years, the FDA has permitted a regulatory loophole under FDA 510(k) which permits the release of new medical devices like the DePuy hip implant, Zimmer NexGen knee implant, and other medical devices, to be placed onto the market without first receiving a comprehensive review by the FDA. How? Because this loophole permits implant manufacturers, like DePuy, to obtain FDA approval if a medical device manufacturer shows that its device is “substantially equivalent” in safety and effectiveness to another FDA approved device.
Dr. Stephen Serlin was summoned at 5am on February 24th, 1993 to perform an emergency C-section for Marlayna’s mother, Dawn Kineke. He did not arrive at the hospital until 7am, and the procedure didn’t begin until 8:14am. In that time, Marlayna suffered fetal asphyxia from umbilical cord compression within the womb, which caused cerebral palsy and a host of additional developmental issues.
In fact, some hip replacement surgeons have argued that hip implant and joint replacement surgery is one of the most important surgical advances over the last century. Because of its popularity, and potential profitability, hip manufacturers such as DePuy, Johnson & Johnson, Zimmer, and others have been competing to capture this potentially lucrative market. Unfortunately, as has been suggested with DePuy, sometimes manufacturers are in such a rush to roll out a “new and improved” implant device, they fail to properly test whether the hip, knee, or other joint implant is better than those that already existed on the market.
The Lincoln Specialty Care Center has had 2 routine inspections between November 2008 and October 2010. During this time period, the facility had 57 cited deficiencies. At an average of 25 deficiencies per visit, the Lincoln Specialty Care Center acquired almost double the amount of citations that some of the other troublesome nursing homes we’ve discussed have acquired.
Martin Chieng Were, M.D., M.S., a Regenstrief Institute investigator and assistant professor of medicine at the Indiana University School of Medicine, has received a $420,000 award from the Harold Amos Medical Faculty Development Program of the 
Silver Care Health Center has had two routine inspections in the two year period from November 2008 through October 2010. During those two routine inspections, the Silver Care Health Care Center was cited for 31 deficiencies. The Silver Care nursing home was cited for numerous violations, i.e. life safety code standard violations, housekeeping, drug regimen not being free of unnecessary drugs, and life safety from fire issues. A number of these deficiencies were considered widespread and able to cause more than minimal harm.